BioSpace News Archive

Policy

Aradigm Submits Marketing Authorisation Application (MAA) to EMA for EU Marketing Approval of Linhaliq in Non-Cystic Fibrosis Bronchiectasis

Aradigm Corporation announced it has submitted its Marketing Authorisation Application (MAA) to European Medicines Agency (EMA) for Linhaliq™ for the treatment of non-cystic fibrosis bronchiectasis (NCFBE) patients with chronic lung infection with Pseudomonas aeruginosa (P. aeruginosa).

March 9, 2018
·
6 min read
Business

Kristy L. Weber, MD, named first vice president of the American Academy of Orthopaedic Surgeons

The new role is the second in a four-year term of volunteer service with Dr. Weber serving as the first female president of the Academy in 2019-20.

March 9, 2018
·
3 min read
Drug Development

MiNA Therapeutics Announces Publication of Pre-Clinical Data Supporting Therapeutic Potential of Clinical Candidate MTL-CEBPA in Liver Cancer and Liver Disease

Data published in oncogene demonstrate improvement of liver function and increased survival in multiple disease models

March 9, 2018
·
3 min read
FDA

FDA Approves Pivotal Clinical Trial for Technology to Treat Overactive Bladder

Device works by sending out electrical impulses to the tibial nerve which takes these signals to the part of the brain that controls bladder response.

March 9, 2018
·
1 min read
Business

Intec Pharma Reports Fourth Quarter and Year End 2017 Financial Results and Business Update

More than 300 patients enrolled in pivotal Phase 3 ACCORDANCE Trial Gastroscopy safety sub-study successfully completed.

March 9, 2018
·
27 min read
Genetown

Myomo Announces Participation at Upcoming Investor and Partnering Conferences

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that Chairman and Chief Executive Officer Paul R. Gudonis will be participating at two upcoming investor, partnering and collaboration conferences.

March 9, 2018
·
2 min read